Related Experiment Video
Updated: Feb 7, 2026

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
Factors associated with intravenous lidocaine in pediatric patients undergoing laparoscopic appendectomy - a
Christian P Both1, Jörg Thomas1, Philipp K Bühler1
1Department of Anesthesia, University Children's Hospital, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Insights
Intravenous lidocaine was safely administered to pediatric patients undergoing laparoscopic appendectomy. This study found no adverse effects, supporting its use in children for this procedure.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Pharmacology
Background:
- Intravenous lidocaine is increasingly used perioperatively for its beneficial effects in adults undergoing surgery.
- Its use in pediatric laparoscopic procedures, like appendectomy, is less studied.
- Lidocaine was integrated into standard care for pediatric laparoscopic surgeries at University Children's Hospital Zurich in mid-2016.
Purpose of the Study:
- To evaluate the safety and potential adverse effects of perioperative intravenous lidocaine in children undergoing laparoscopic appendectomy.
- To compare outcomes between pediatric patients receiving lidocaine and those who did not.
Main Methods:
- Retrospective analysis of 116 pediatric patients undergoing laparoscopic appendectomy in 2016.
- Comparison of patients who received intravenous lidocaine (post-07/01/2016) versus those who did not (pre-07/01/2016).
- Evaluation for systemic toxicity, neurological/cardiovascular effects, behavioral changes, hemodynamic instability, and postoperative outcomes (nausea, vomiting, pain, discharge time, bowel movement, complications).
Main Results:
- Data from 116 patients analyzed; 60 received lidocaine.
- No instances of systemic lidocaine toxicity, neurological impairment, or circulatory disturbances were observed.
- A non-significant trend towards less emergence delirium in the lidocaine group (0 cases vs. 4 cases, p=0.05).
Conclusions:
- Perioperative intravenous lidocaine administration appears safe in pediatric patients undergoing laparoscopic appendectomy under general anesthesia.
- No adverse effects were identified in this retrospective analysis.
- Further research is needed to explore the beneficial effects and pharmacokinetics of intravenous lidocaine in pediatric populations.
Background:
Due to its potential beneficial effects, intra- and postoperative application of intravenous lidocaine has become increasingly accepted over the last couple of years, e.g. in patients undergoing laparoscopic surgical procedures. Based on its beneficial properties, lidocaine was introduced to the standard of care for all pediatric laparoscopic procedures in our institution in mid-2016. In contrast to adult care, scarce data is available regarding the use of perioperative intravenous lidocaine administration in children undergoing laparoscopic procedures, such as an appendectomy.
Methods:
Retrospective analysis of all pediatric patients undergoing laparoscopic appendectomy at the University Children's Hospital Zurich in 2016. Perioperative data, as recorded in the electronic patient data management system, were evaluated for any signs of systemic lidocaine toxicity (neurological and cardiovascular), behavioral deterioration, as well as for hemodynamic instability. Additionally, the incidence of postoperative nausea and vomiting, administration of pain rescue medication, time to hospital discharge and to first bowel movement, as well as any postoperative complications were recorded. Starting on 01/07/2016, all patients undergoing laparoscopic surgery received intravenous lidocaine (1.5 mg/kg body weight (BW) bolus after induction of anesthesia followed by continuous infusion of 1.5 mg/kgBW/h). These patients were then compared to children without lidocaine administration who had undergone laparoscopic appendectomy between 01/01/2016 and 30/06/2016.
Results:
Data of 116 patients was analyzed. Of these, 60 patients received lidocaine. No signs of systemic toxicity, neurologic impairment or circulatory disturbances were noted in any of these patients. A (non-significant) difference in the incidence of emergence delirium was observed (0 cases in the lidocaine group vs. 4 cases in the control group, p = 0.05).
Conclusion:
This retrospective analysis did not reveal any adverse effects in pediatric patients receiving intravenous lidocaine for laparoscopic appendectomy under general anesthesia. However, further trials investigating beneficial effects as well as pharmacokinetic properties of intravenous lidocaine in children are required.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
What is an Experiment?

